跳至主要内容
临床试验/NCT02532543
NCT02532543终止不适用

Prospective, Comparative Volumetric Assessment of Alveolar Ridge Preservation Utilizing Different Bone Grafting Materials (SYMBIOS CORTICAL-CANCELLOUS GRANULE MIX; SYMBIOS OSTEOGRAF LD-300; OSTEOGRAF/N-300) Following Tooth Extraction

University of North Carolina, Chapel Hill2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2016年4月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
16
试验地点
2
主要终点
Total Mean Change in Bone Volume

研究概览

简要总结

This study is intended to provide statistically robust evidence that Symbios Demineralized Cortical-cancellous granule mix, Symbios OsteoGraf LD-300, and OsteoGraf/N-300 combined with Symbios OsteoShield Collagen Resorbable Membrane can adequately support the alveolus during ridge augmentation procedures, reducing the dimensional changes of both the alveolus and the overlying soft tissues. Additionally, a comparison between each material will be made, providing further evidence of each materials' ability to preserve the alveolus. It is intended to define in objective terms the response of the hard and soft tissues to ridge augmentation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provision of informed consent
  • ≥ 18 years and ≤ 75 years
  • Good physical health (ASAI/II)
  • Extraction of maxillary premolar, canine or incisor, or mandibular premolar and canine required
  • Teeth adjacent (mesial and distal) to study site must consist of two stable natural teeth with minimal restorations, without signs of periodontal bone loss (> 3 mm) and/or significant soft tissue deficiencies

排除标准

  • Buccal plate dehiscence and/or fenestration >3mm at study site following extraction
  • Untreated rampant caries and uncontrolled periodontal disease
  • Inadequate oral hygiene (estimated plaque score >20%)
  • Smokers using more than 10 cigarettes or equivalent per day
  • Smokeless tobacco use or e-cigarette use
  • Compromised physical health and/or uncontrolled or severe systemic diseases including:
  • ASA III/IV Metabolic bone disease History of malignancy History or radiotherapy or chemotherapy for malignancy in the past 5 years History of autoimmune disease Long-term steroidal or antibiotic therapy Uncontrolled diabetes Known alcohol or drug abuse
  • Systemic or local disease or condition that would compromise post-operative healing
  • Use of any substance or medication that will influence bone metabolism
  • Known pregnancy
  • Unable or unwilling to return for follow-up visits for a period of 6 months
  • Unlikely to be able to comply with study procedures according to Investigators judgement
  • Involvement in the planning and conduct of the study
  • Previous enrollment or randomization of treatment in the present study

结局指标

主要结局

Total Mean Change in Bone Volume

时间窗: time of extraction to 3 months post extraction

The change in bone volume at 3 months following extraction will be calculated using data from DICOM images acquired by Cone Beam Computed Tomography (CBCT) using 3D software

次要结局

  • Mean Soft Tissue Dimensional Changes-Vertical(time of extraction to 3 months post extraction)
  • Mean Osseous Dimensional Changes-Vertical(time of extraction to 3 months post extraction)
  • Mean Osseous Dimensional Changes-Horizontal(time of extraction to 3 months post extraction)
  • Total Mean Change in Soft Tissue Volume(time of extraction to 3 months post extraction)
  • Mean Soft Tissue Dimensional Changes-Horizontal(time of extraction to 3 months post extraction)
  • Soft Tissue Dimensional Change at Month 6(Month 6)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验